热门资讯> 正文
MiNK Therapeutics申请为股东出售464万股普通股
2024-08-14 04:45
- MiNK Therapeutics (NASDAQ:INKT) filed a prospectus related to the offer and sale of 4,640,000 shares of common stock by the selling stockholder.
- This prospectus is not an offer to sell.
- Filing
More on MiNK Therapeutics
- Seeking Alpha’s Quant Rating on MiNK Therapeutics
- Historical earnings data for MiNK Therapeutics
- Financial information for MiNK Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
